Flu season is officially upon us, and County Executive George Latimer and Health Commissioner Dr. Sherlita Amler are encouraging residents to get vaccinated to remain healthy and safe.
The Westchester County Health Department will offer both the flu vaccine and COVID-19 bivalent booster by appointment. every Monday and Friday in October from 10 a.m. to 3 p.m., at 134 Court Street in White Plains.
Latimer said: As we have seen since over the past two years, COVID-19 infection rates tend to rise during the fall and winter months, and the same goes for transmission of the flu. We should all be taking careful precautions to prevent the spread of COVID and the flu, and getting your vaccines will help us do that. It is strongly recommended to get both the bivalent COVID booster and the flu shot at the same time, to better protect yourself from both illnesses.
Health Commissioner Sherlita Amler, MD, said: Combining vaccines is safe, and it is much more convenient to schedule both at the same time. Children often receive multiple shots at once, and you are much less likely to skip a vaccine if both are given together. Vaccines for flu and COVID-19 offer the best protection we have to fight these diseases, so the sooner you get vaccinated, the better.
Go to the Westchester County Health website to book your vaccine visit. Flu shots are available for anyone age three and older, and high-dose flu vaccine is available for people ages 65 and older. Children may receive a COVID-19 vaccine at the same time as they get a flu shot on Friday mornings this month. Bivalent COVID-19 boosters are available for adults and children ages 12 and up who received their most recent COVID-19 vaccine at least two months ago.
Additional Health Department Flu and COVID Bivalent Booster vaccine clinics are as follows:
Thursday, Oct. 20, 20222 to 6:30 p.m.Yonkers Riverfront LibraryMain Entrance Atrium and Childrens Library on Second Floor1 Larkin Center, Yonkers, NY 10701
Friday, Oct. 28, 20229 a.m. to 1 p.m.Don Bosco Community Center22 Don Bosco Place, Port Chester, NY 10573
Thursday, Nov. 3, 20222 to 6:30 p.m.Yonkers Riverfront LibraryMain Entrance Atrium and Childrens Library on Second Floor1 Larkin Center, Yonkers, NY 10701
For more information, visit the Health Department Website.
A study in Japan finds antibody response to the Moderna COVID-19 mRNA vaccine does not vary depending on the time of day when the dose was received.
Many physiological and behavioral functions including the immune system exhibit circadian rhythms. Several studies have investigated if the immune response to COVID-19 vaccines varies depending on the time of day when the dose was received, but results were dependent on type of vaccine, participants' age and sex. Now, a study conducted by scientists at Hokkaido University and colleagues in Japan has found no association between antibody response to COVID-19 vaccine and time of day of vaccination. They do add to the body of literature that could ultimately guide vaccination optimization. The findings were published in the Journal of Biological Rhythms.
The researchers recruited their study participants from Hokkaido University employees and students who received their first dose of the mRNA-1273 (Moderna) vaccine two to four weeks earlier. Those who had been previously infected with COVID-19 were excluded. The study group did not include shift workers, a crucial difference between this and some previous studies on healthcare workers.
The team collected demographic data on the final group of 332 Japanese participants and took blood samples to measure antibody titers against SARS-CoV-2. They then conducted statistical analyses to find out if there were associations between the time of day when the participants received their vaccine dose, any of the demographic characteristics, and the immune response.
"Our analyses revealed no significant association between the time of day of vaccination and the SARS-CoV-2 antibody concentration, but we did find that antibody titers decreased in participants aged 50 to 64, which is consistent with previous studies," says Hokkaido University physiologist Dr. Yujiro Yamanaka, who specializes in studying chronobiology.
Conflicting results between studies could be explained by various factors, including differences in sex, age, physical activity, and natural immune system, the type of vaccine received, number of days after vaccination, and differences in vaccine dose. Scientists also need to more fully understand whether other factors like race play a role.
The limitations reduce our ability to conclusively rule out the possibility that circadian rhythms influence antibody response to vaccination. Larger randomized studies are needed to more conclusively guide vaccination strategies regarding a time-of-day variable."
Dr. Yujiro Yamanaka, Physiologist, Hokkaido University
Source:
Journal reference:
Yamanaka, Y.,et al.(2022) Time of Day of Vaccination Does Not Associate With SARSCoV2 Antibody Titer Following First Dose of mRNA COVID19 Vaccine. Journal of Biological Rhythms.doi.org/10.1177/07487304221124661.
BRUSSELSDuring a hearing today on the European Unions COVID-19 response, Pfizers president of international developed markets, Janine Small, admitted that its vaccine had never been tested before its release to the general public on its ability to prevent the transmission of COVID when asked by Dutch politician and a currentMember of the European Parliament(MEP) Robert Rob Roos.
Regarding the question around did we know about stopping immunization before it entered the marketNo., Small replied with a smirk when asked by Roos if the Pfizer COVID vaccine was ever tested to stop the transmission of the virus before it entered the market.
She continued, We have to really move at the speed of science to really understand what is taking place in the market.
It was not clear from the questioning of Ms. Small if she were referring to the Pfizer BioNTech (BNT162b2) vaccine which is authorized under Emergency Use Authorization or Comirnaty which is the FDA-approved vaccine. Under an Emergency Use Authorization, vaccines cannot be mandated.
According to the August 2022 article, The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you need to know, it states that there is modest vaccine impact on transmission to prevent COVID infection.
In response to the COVID-19 pandemic, the EU implemented a wide range of health policies with its EU Vaccines Strategy and initiatives, one being EU Digital COVID Certificates which exempted persons from free movement restrictions. The EU implemented free movement restrictions to slow down the spread of coronavirus and protect the health and well-being of all Europeans.
EU Parliamentarian Roos, exposed an alleged misinformation campaign by Pfizer with the release of his video tweet today. In it he called the actions criminal, scandalous and a cheap lie.
Below is a transcript of Roos Twitter post:
If you dont get vaccinated, youre antisocial. This is what the Dutch prime minister and health minister told us. You dont get vaccinated just for yourself, but also for others. You do it for all of society, thats what they said. Today, this turned out to be complete nonsense.
In a COVID hearing in the European Parliament, one of the Pfizer directors just admitted to me at the time of introduction, the vaccine had never been tested on stopping the transmission of the virus.
This removes the entire legal basis for the COVID Passport. The COVID passport that led to massive institutional discrimination as people lost access to essential parts of society. I find this to be shocking, even criminal.
This is scandalous. Millions of people worldwide felt forced to get vaccinated because of the myth that you do it for others. Now this turned out to be a cheap lie.
Most vulnerable protected against COVID-19 and flu.
Over a million vaccines have been delivered to protect against the latest strains of flu and COVID-19 in the latest efforts to relieve pressure on the NHS over winter.
Frontline healthcare staff and the countrys most vulnerable have been immunised at speed with 80.2% of all care home residents being fully vaccinated since the rollout began in September.
The next groups in line for their vaccines over 65s and those at high-risk are receiving a scheduled appointment and 50-64 year olds will soon be invited to book an appointment. Anyone who has missed an appointment can reschedule through the NHS Inform online booking portal.
The COVID-19 vaccine is being given at the same time as the flu jab where possible, and so far 94% of those invited have had both at the same appointment. Over two million Scots will be offered both vaccines over the next three months a pace that aims to maintain Scotlands place as a leading nation on vaccine uptake.
Health Secretary Humza Yousaf said:
This impressive uptake is testament to the frontline staff who got us through the pandemic and continue to protect our population and NHS from the threats that winter brings.
Scotland remains steadfast in the effort to protect everyone continuing the huge success of the vaccination programme since it was first rolled out in December 2020.
COVID-19 has not gone away and I call on everyone to take up the offer of a booster as soon as their invitation arrives to protect themselves, their families and the NHS.
BACKGROUND
1,369,270 COVID-19 and flu vaccines have been delivered since the winter vaccine programme launched.
Both new bivalent vaccines, which target Omicron and the original variant of COVID-19, are being deployed alongside existing vaccines, though the vaccination individuals receive will depend on age and vaccine availability. Both the current and new bivalent vaccines provide good protection from severe illness and hospitalisation from known COVID-19 variants.
Rearrange or opt-out of your vaccination appointment | NHS inform
Winter vaccines | NHS inform
Yes. The first mass vaccination programme started in early December 2020 and the number of vaccination doses administered is updated on a daily basis here. At least 13 different vaccines (across 4 platforms) have been administered. Campaigns have started in 206 economies.
The Pfizer/BioNtech Comirnaty vaccine was listed for WHO Emergency Use Listing (EUL) on 31 December 2020. The SII/Covishield and AstraZeneca/AZD1222 vaccines (developed by AstraZeneca/Oxford and manufactured by the Serum Institute of India and SK Bio respectively) were given EUL on 16 February. The Janssen/Ad26.COV 2.S developed by Johnson & Johnson, was listed for EUL on 12 March 2021. The Moderna COVID-19 vaccine (mRNA 1273) was listed for EUL on 30 April 2021 and the Sinopharm COVID-19 vaccine was listed for EUL on 7 May 2021. The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG).
For further information, see here.
Once vaccines are demonstrated to be safe and efficacious, they must be approved by national regulators, manufactured to exacting standards, and distributed. WHO is working with partners around the world to help coordinate key steps in this process, including to facilitate equitable access to safe and effective COVID-19 vaccines for the billions of people who will need them. More information about COVID-19 vaccine development is available here.
Note: ADHS is open Monday through Friday from 8 a.m. to 5 p.m., except state holidays.
Any documents contained on this Web site that are translations from original text written in English are unofficial and not binding on this state or a political subdivision of this state. To learn about how ADHS collects information about website users, please review our Website Privacy Policy. Los documentos que son traducciones al Espaol y que se encuentran en esta pgina Web no tienen validez oficial ni legal en este Estado o en alguna entidad politica del mismo. 2009 - Arizona Department of Health Services
The public notice and agenda for each public meeting is posted in the lobby of this Department and on the Public Meeting Notices page.
Coronaviruses are a family of viruses known for containing strains that cause potentially deadly diseases in mammals and birds.
In humans they're typically spread via airborne droplets of fluid produced by infected individuals.
Of the seven coronaviruses kown to infect humans, four spread with seasonal regularity, causing anything from mild cold-like symptoms to flu-like discomforts.
A few more notable strains, including SARS-CoV-2 (responsible for COVID-19), and those responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), can cause death in humans. The cause of death is complex, though is typically the result of heightened immune responses causing damage in multiple systems throughout the body.
First described in detail in the 1960s, the coronavirus gets its name from a distinctive corona or 'crown' of sugary-proteins that projects from the envelope surrounding the particle. Encoding the virus's make-up is the longest genome of any RNA-based virus a single strand of nucleic acid roughly 26,000 to 32,000 bases long.
There are four known genuses in the family, named Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus. The first two only infect mammals, including bats, pigs, cats, and humans. Gammacoronavirus mostly infects birds such as poultry, while Deltacoronavirus can infect both birds and mammals.
Coronaviruses can give rise to a variety of symptoms in different animals. In a high percentage of cases, infection causes no symptoms at all. These individuals can still easily spread the virus without knowing they're infected.
While some strains cause diarrhoea in pigs and in turkeys, in humans infections are usually compared to a bad cold, causing mild to moderate upper respiratory problems such as a runny nose and sore throat.
There are a handful of lethal exceptions, which have had a devastating impact on livestock and human health around the globe. Symptoms in these cases tend to start with a sore throat and fever.
In the specific case of the novel coronavirus COVID-19, most of those infected experience a fever within five days of being infected, followed by a cough. This differs to a flu, which tends to start with a cough.
Severe cases can require hospitalisation from respiratory distress within about a week of the first symptoms showing. Where symptoms continue to worsen, death can follow within two weeks to nearly two months, depending on prognosis and medical care.
COVID-19 is the illness that presents on being infected by a deadly coronavirus called SARS-CoV-2.
This SARS-related virus was first identified in the Chinese city of Wuhan in late 2019. Snakes were originally suspected as a potential source for the outbreak, though other experts have deemed this unlikely and proposed bats as a reservoir instead. Pangolins have been implicated as a potential link in the transfer chain.
As of April 2020, the search for the animal origin of COVID-19 is ongoing.
At the time of writing, numbers of infected are still on the rise, with a mortality rate that varies significantly around the world from less than one to more than 10 percent.
The SARS-CoV-2 pandemic has caused significant disruptions to economies and social activities around the globe throughout 2020. Treatments and protective therapies are currently in development, with programs expected to begin vaccinations in the US by the start of 2021.
SARS was first recognised as a distinct strain of coronavirus in 2003. The source of the virus has never been clear, though the first human infections can be traced back to the Chinese province of Guangdong in 2002.
The virus then became a pandemic, causing more than 8,000 infections of an influenza-like disease in 26 countries with close to 800 deaths.
MERS was first identified in Saudi Arabia in 2012 in people displaying symptoms of fever, cough, shortness of breath and occasionally gastrointestinal problems such as diarrhoea. An animal source for the virus has never been officially confirmed, though evidence points to dromedary camels as a potential reservoir of infection.
The World Health Organisation has identified around 2,500 cases of infection in 27 countries since initial outbreaks, resulting in nearly 860 deaths.
All articles are determined by fact checkers to be correct and relevant at the time of publishing. Information published on the coronavirus during the 2020 COVID-19 pandemic may be updated frequently to reflect the dynamic nature of current understanding.
The U.S. on Wednesday authorized updated COVID-19 boosters for children as young as 5, seeking to expand protection ahead of an expected winter wave.
Tweaked boosters rolled out for Americans 12 and older last month, doses modified to target todays most common and contagious omicron relative. While there wasnt a big rush, federal health officials are urging that people seek the extra protection ahead of holiday gatherings.
Now the Food and Drug Administration has given a green light for elementary school-age kids to get the updated booster doses, too -- one made by Pfizer for 5- to 11-year-olds, and a version from rival Moderna for those as young as 6.
Theres one more step before parents can bring their kids in for the new shot: The Centers for Disease Control and Prevention, which recommends how vaccines are used, must sign off.
Americans may be tired of repeated calls to get boosted against COVID-19 but experts say the updated shots have an advantage: They contain half the recipe that targeted the original coronavirus strain and half protection against the dominant BA.4 and BA.5 omicron versions.
These combination or bivalent boosters are designed to broaden immune defenses so that people are better protected against serious illness whether they encounter an omicron relative in the coming months -- or a different mutant thats more like the original virus.
We want to have the best of both worlds, Pfizers Dr. Bill Gruber, a pediatrician, told The Associated Press. He hopes the updated shots will re-energize interest in protecting children for the winter.
The updated boosters are extremely important for keeping kids healthy and in school, said Dr. Jason Newland, a pediatric infectious disease specialist at Washington University in St. Louis.
Parents should know there is no concern from the safety perspective with the bivalent vaccines, whether Moderna or Pfizer, Newland added.
Only people whove gotten their initial vaccinations -- with any of the original-formula versions -- qualify for an updated booster. That means about three-fourths of Americans 12 and older are eligible. As of last weekend, only at least 13 million had gotten an updated booster, White House COVID-19 coordinator Dr. Ashish Jha estimated Tuesday.
To pediatricians chagrin, getting children their first vaccinations has been tougher. Less than a third of 5- to 11-year-olds have had their two primary doses and thus would qualify for the new booster.
This age group will get kid-size doses of the new omicron-targeting booster and they can receive it at least two months after their last dose, whether that was their primary vaccination series or an earlier booster, the FDA said.
Vaccination remains the most effective measure to prevent the severe consequences of COVID-19, Dr. Peter Marks, FDAs vaccine chief, said in a statement.
While children tend to get less seriously ill than adults, as the various waves of COVID-19 have occurred, more children have gotten sick with the disease and have been hospitalized, Marks said.
For the updated booster made by Pfizer and its partner BioNTech, 5- to 11-year-olds would get a third of the dose that anyone 12 and older already receives. Pfizer said it could ship up to 6 million kid-sized doses within a week of authorization, in addition to ongoing shipments of adult-sized doses.
Until now, Modernas updated booster was cleared only for adults. FDA just expanded that adult bivalent dosage to 12- to 17-year-olds, and authorized half the dose for kids ages 6 to 11.
As for even younger tots, first vaccinations didnt open for the under-5 age group until mid-June -- and it will be several more months before regulators decide if theyll also need a booster using the updated recipe.
Exactly how much protection does an updated COVID-19 booster shot offer? Thats hard to know. Pfizer and Moderna are starting studies in young children.
But the FDA cleared the COVID-19 booster tweaks without requiring human test results -- just like it approves yearly changes to flu vaccines. Thats partly because both companies already had studied experimental shots tweaked to target prior COVID-19 variants, including an earlier omicron version, and found they safely revved up virus-fighting antibodies.
Its clearly a better vaccine, an important upgrade from what we had before, Jha said earlier this week.
Jha urged adults to get their updated shot in October like they get flu vaccinations or at least well before holiday gatherings with high-risk family and friends. People whove recently had COVID-19 still need the booster but can wait about three months, he added.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institutes Department of Science Education. The AP is solely responsible for all content.
Whats more, the mutations in these new strains could make them more immune-evasive, Adalja says. However, even if thats the case, it doesnt necessarily mean they will render protections from the vaccines or a prior infection completely powerless.
The shots weve had access to so far have helped reduce the risk of hospitalization and death in many, regardless of the variants circulating, points out Aditya Shah, an infectious disease specialist at the Mayo Clinic. We hope that that remains, because we dont want to overwhelm the health care systems this winter.
See more Health & Wellness offers >
More than 3,300 Americans are still being hospitalized every day for COVID-19, data from the Centers for Disease Control and Prevention (CDC) shows. And with apotentially rough flu seasonon the horizon, health care workers are bracing for numbers to swell. (During the 20192020 flu season, 390,000 Americans were hospitalized with the illness, according to the CDC.) Cases of RSV (or respiratory syncytial virus, which is most dangerous in infants and older adults) also typically spike in the cold-weather months.
We are entering into the winter months, where no matter what the respiratory disease is, theres always a risk of an uptick in respiratory diseases, Anthony Fauci, M.D., chief medical adviser to the president, said during a recent USC Annenberg Center for Health Journalism webinar.
One thing that could help subdue a storm of hospitalizations this winter: theupdated COVID-19 bivalent booster shots, which are now available to vaccinated people age 12 and older. Arecent reportfrom the Commonwealth Fund finds that if 80 percent of eligible Americans roll up their sleeves for the shot which targets omicrons BA.4 and BA.5 and also the original strain of the virus for a broad swath of protection 936,706 hospitalizations due to COVID-19 could be averted and nearly 90,000 lives could be saved.
If the booster uptake is even equivalent to recent flu vaccine uptake (about half of adults got their flu shot in 20202021, the latest data available shows), more than 75,000 deaths and 745,409 hospitalizations due to COVID-19 could be prevented. Still, few adults (about 4 percent) have received the new booster. About 20 percent of Americans say they arent even aware of them,a recent pollfrom the Kaiser Family Foundation finds. Older adults are the exception, with about half (45 percent) of people age 65 and older reporting they have received the updated booster or intend to get it as soon as possible.
Overview
Influenza is a viral infection that attacks your respiratory system your nose, throat and lungs. Influenza is commonly called the flu, but it's not the same as stomach "flu" viruses that cause diarrhea and vomiting.
For most people, the flu resolves on its own. But sometimes, influenza and its complications can be deadly. People at higher risk of developing flu complications include:
Though the annual influenza vaccine isn't 100% effective, it's still your best defense against the flu.
At first, the flu may seem like a common cold with a runny nose, sneezing and sore throat. But colds usually develop slowly, whereas the flu tends to come on suddenly. And although a cold can be a bother, you usually feel much worse with the flu.
Common signs and symptoms of the flu include:
Most people who get the flu can treat themselves at home and often don't need to see a doctor.
If you have flu symptoms and are at risk of complications, see your doctor right away. Taking antiviral drugs may reduce the length of your illness and help prevent more-serious problems.
If you have emergency signs and symptoms of the flu, get medical care right away. For adults, emergency signs and symptoms can include:
Emergency signs and symptoms in children can include:
Sign up for free, and stay up to date on research advancements, health tips and current health topics, like COVID-19, plus expertise on managing health.
To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail.
Subscribe!
You'll soon start receiving the latest Mayo Clinic health information you requested in your inbox.
Please, try again in a couple of minutes
Retry
Influenza viruses travel through the air in droplets when someone with the infection coughs, sneezes or talks. You can inhale the droplets directly, or you can pick up the germs from an object such as a telephone or computer keyboard and then transfer them to your eyes, nose or mouth.
People with the virus are likely contagious from about a day before symptoms appear until about five days after they start. Children and people with weakened immune systems may be contagious for a slightly longer time.
Influenza viruses are constantly changing, with new strains appearing regularly. If you've had influenza in the past, your body has already made antibodies to fight that specific strain of the virus. If future influenza viruses are similar to those you've encountered before, either by having the disease or by getting vaccinated, those antibodies may prevent infection or lessen its severity. But antibody levels may decline over time.
Also, antibodies against influenza viruses you've encountered in the past may not protect you from new influenza strains that can be very different viruses from what you had before.
Factors that may increase your risk of developing the flu or its complications include:
If you're young and healthy, the flu usually isn't serious. Although you may feel miserable while you have it, the flu usually goes away in a week or two with no lasting effects. But children and adults at high risk may develop complications that may include:
Pneumonia is one of the most serious complications. For older adults and people with a chronic illness, pneumonia can be deadly.
Mayo Clinic offers flu shots in Arizona, Florida and Minnesota.
The Centers for Disease Control and Prevention (CDC) recommends annual flu vaccination for everyone age 6 months or older. The flu vaccine can reduce your risk of the flu and its severity and lower the risk of having serious illness from the flu and needing to stay in the hospital.
Flu vaccination is especially important this season because the flu and coronavirus disease 2019 (COVID-19) cause similar symptoms. Flu vaccination could reduce symptoms that might be confused with those caused by COVID-19. Preventing the flu and reducing the severity of flu illness and hospitalizations could also lessen the number of people needing to stay in the hospital.
It may be possible to get a COVID-19 vaccine at the same time as your flu vaccine.
This year's seasonal flu vaccine provides protection from the four influenza viruses that are expected to be the most common during the year's flu season. This year, the vaccine will be available as an injection and as a nasal spray.
The nasal spray isn't recommended for some groups, such as:
If you have an egg allergy, you can still get a flu vaccine.
DeeDee Stiepan: Getting your annual flu vaccine is especially important this season.
Gregory Poland, M.D., Infectious Diseases, Mayo Clinic: Where we have COVID spreading, we will very likely have influenza spreading.
DeeDee Stiepan: The flu vaccine won't protect against COVID-19 but it can help reduce the chance of getting the flu.
Dr. Poland: The symptoms of COVID and influenza overlap almost exactly in their initial manifestations with the exception of the loss of smell, loss of taste. That would be very unusual in influenza.
DeeDee Stiepan: Getting a flu vaccine helps rule out influenza if you develop respiratory issues and helps reduce stress on the health care system.
Dr. Poland: Every American, age six months and older, get a flu vaccine. An opportunity we have in the context of this twindemic is not only to get our flu vaccines but to remember these non-pharmaceutical interventions: the mask wearing, physical distancing. While they prevent COVID, they also decrease the risk of influenza.
DeeDee Stiepan: For the Mayo Clinic News Network, I'm DeeDee Stiepan.
The influenza vaccine isn't 100% effective, so it's also important to take several measures to reduce the spread of infection, including:
Avoid crowds. The flu spreads easily wherever people gather in child care centers, schools, office buildings, auditoriums and public transportation. By avoiding crowds during peak flu season, you reduce your chances of infection.
Also avoid anyone who is sick. And if you're sick, stay home for at least 24 hours after your fever is gone so that you lessen your chance of infecting others.
Both COVID-19 and the flu may be spreading at the same time. Your local health department and the CDC may suggest other precautions to reduce your risk of COVID-19 or the flu if you haven't been fully vaccinated. For example, you may need to practice social distancing (physical distancing) and stay at least 6 feet (2 meters) from others outside your household. You may also need to wear a cloth face mask when indoors with people outside your household and when outdoors in crowded areas. If you're fully vaccinated and are in an area with a high number of new COVID-19 cases in the last week, the CDC also recommends wearing a mask indoors in public and outdoors in crowded areas or when you're in close contact with unvaccinated people.
Sept. 21, 2022
